Our Studies : Frontotemporal Dementia Research (FTD)

Frontotemporal Dementia (FTD)

Approximately 5% of all dementia patients present with Frontotemporal Dementia (FTD), including ~10-20% of those dementia patients before the age of 65 years. Though FTD is unique in its loss of social cognition or language disturbances, it shows overlap with other diseases, such as Alzheimer Disease (AD).

Existing FTD genetic efforts are often limited to non-Hispanic white cohorts, clearly indicating a gap of knowledge on genetic factors unique to underrepresented populations such as Hispanics and African Americans or shared across populations.

The John P. Hussman Institute for Human Genomics (HIHG) is dedicated to addressing health disparities in genomic research. Results from these studies will translate into better diagnoses and eventual treatments for a broader community of people. The HIHG team led by Drs. Nuytemans, Pericak-Vance and Vance are committed to extend the DLB research to diverse populations to identify novel variants and understand genetic contributions to DLB across populations.

For more information, or to participate in our Frontotemporal Dementia study, please contact our study coordinator:

Antonella Grana